Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

✍ Scribed by D.B. Blossom; R.H. Beigi; J.J. Farrell; W. Mackay; B. Qadadri; D.R. Brown; S. Rwambuya; C.J. Walker; F.S. Kambugu; F.W. Abdul-Karim; C.C. Whalen; R.A. Salata

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 151 KB
• Volume: 79
• Category: Article
• ISSN: 0146-6615
• DOI: 10.1002/jmv.20817

✦ Synopsis

Abstract

Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross‐sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2% (49/106). HIV prevalence was 34.9% (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy‐three percent (27/37) of HIV‐positive women versus 16% (10/63) of HIV‐negative women had abnormal Pap smears (P < 0.0001). Among HIV‐positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population. J. Med. Virol. 79: 758–765, 2007. © 2007 Wiley‐Liss, Inc.